Breaking News Instant updates and real-time market news.

PAVM

PAVmed

$0.96

-0.03 (-3.03%)

09:33
08/15/19
08/15
09:33
08/15/19
09:33

PAVmed completes clinical safety study procedures for CarpX 510 resubmission

PAVmed announced that all 20 patients of its first-in-human 510(k) clinical safety study underwent successful CarpX procedures. The study is being conducted to support PAVmed's planned 510(k) re-submission to the U.S. FDA seeking marketing clearance of its CarpX minimally invasive carpal tunnel release device. "We are excited to have achieved this critical milestone," said Lishan Aklog, M.D., PAVmed's Chairman and CEO. "Our success with this study brings us one step closer to fulfilling our mission to transform how carpal tunnel syndrome is treated for millions of people worldwide, representing a billion-dollar market opportunity in the U.S. alone. CarpX performed flawlessly as a precision cutting device in these 20 consecutive patients. Using CarpX, surgeons were able to replicate the outstanding results of our pre-clinical testing and achieve the same anatomic results as traditional open surgery - complete and precise cutting of the transverse carpal ligament - using a minimally invasive approach." As per the protocol, patients are undergoing post-operative clinical follow-up at two weeks and 90 days. All of the patients who have completed their follow-up have passed the study's specified primary safety endpoint and, based on clinical observations, it is expected that all of the remaining patients will as well. PAVmed will resubmit the CarpX 510(k) application incorporating the clinical safety and effectiveness data from the study once 90-day follow-up is completed in all 20 patients.

PAVM PAVmed
$0.96

-0.03 (-3.03%)

01/14/19
MAXM
01/14/19
NO CHANGE
Target $3
MAXM
Buy
PAVmed price target lowered to $3 from $4 at Maxim
Maxim analyst Anthony Vendetti lowered his price target on PAVmed to $3 following the FDA recommendation to "conduct human clinical studies to address any remaining substantial equivalence issues" for its CarpX program. The analyst notes that while the company intends to utilize its first-in-human clinical study in New Zealand plus a second site to satisfy the FDA's requirements, the CarpX timeline will be pushed out.

TODAY'S FREE FLY STORIES

NBRV

Nabriva Therapeutics

$2.13

-0.14 (-6.17%)

14:28
08/19/19
08/19
14:28
08/19/19
14:28
Hot Stocks
Breaking Hot Stocks news story on Nabriva Therapeutics »

Nabriva Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 09

    Sep

LAZ

Lazard

$33.90

0.77 (2.32%)

14:24
08/19/19
08/19
14:24
08/19/19
14:24
Periodicals
Breaking Periodicals news story on Lazard »

Lazard seen as top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LFGP

Ledyard Financial Group

$0.00

(0.00%)

14:21
08/19/19
08/19
14:21
08/19/19
14:21
Hot Stocks
Ledyard Financial Group announces 120K share repurchase plan »

Ledyard Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$41.69

1.11 (2.74%)

14:19
08/19/19
08/19
14:19
08/19/19
14:19
Hot Stocks
Twitter says will no longer accept advertising from state-controlled news media »

In a blog post, Twitter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

  • 20

    Aug

  • 24

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
08/19/19
08/19
14:17
08/19/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
08/19/19
08/19
14:16
08/19/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSS

Kohl's

$48.17

2.66 (5.84%)

, TJX

TJX

$51.87

0.45 (0.88%)

14:11
08/19/19
08/19
14:11
08/19/19
14:11
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

KSS

Kohl's

$48.17

2.66 (5.84%)

TJX

TJX

$51.87

0.45 (0.88%)

MDT

Medtronic

$103.90

1.17 (1.14%)

HD

Home Depot

$208.01

4.37 (2.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 20

    Aug

  • 20

    Aug

  • 20

    Aug

  • 04

    Sep

  • 09

    Sep

14:10
08/19/19
08/19
14:10
08/19/19
14:10
General news
Treasury Action: Treasuries remain heavy »

Treasury Action:…

CHE

Chemed

$434.70

4.53 (1.05%)

14:09
08/19/19
08/19
14:09
08/19/19
14:09
Hot Stocks
Chemed VP Michael Witzeman sells almost $2M in company shares »

Chemed VP Michael…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:05
08/19/19
08/19
14:05
08/19/19
14:05
General news
Fed's Rosengren said he believes monetary and fiscal policy are already accommodative »

Fed's Rosengren said…

AAPL

Apple

$211.93

5.49 (2.66%)

, MSFT

Microsoft

$138.27

2.14 (1.57%)

14:02
08/19/19
08/19
14:02
08/19/19
14:02
Periodicals
Microsoft hires former head of Apple's Siri efforts, The Information says »

Microsoft (MSFT) has…

AAPL

Apple

$211.93

5.49 (2.66%)

MSFT

Microsoft

$138.27

2.14 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

  • 27

    Oct

RRR

Red Rock Resorts

$19.46

0.75 (4.01%)

, AES

AES Corp.

$15.46

0.25 (1.64%)

13:44
08/19/19
08/19
13:44
08/19/19
13:44
On The Fly
Fly Insider: Red Rock Resorts, Walgreen's among weeks notable insider trades »

Welcome to "Fly Insider,"…

RRR

Red Rock Resorts

$19.46

0.75 (4.01%)

AES

AES Corp.

$15.46

0.25 (1.64%)

GE

General Electric

$8.66

-0.13 (-1.48%)

MD

Mednax

$22.28

0.62 (2.86%)

CFR

Cullen/Frost

$85.74

0.95 (1.12%)

TWNK

Hostess Brands

$14.01

0.06 (0.43%)

WEN

Wendy's

$20.44

0.5 (2.51%)

PSA

Public Storage

$260.91

2.23 (0.86%)

AYX

Alteryx

$133.18

-0.57 (-0.43%)

WBA

Walgreens Boots Alliance

$51.40

1.3975 (2.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 03

    Sep

  • 04

    Sep

  • 09

    Sep

  • 23

    Sep

  • 02

    Oct

  • 30

    Oct

  • 13

    Nov

GIG

GigCapital

$10.30

(0.00%)

13:43
08/19/19
08/19
13:43
08/19/19
13:43
Hot Stocks
GigCapital announces launching of de-SPACing efforts of Kaleyra combination »

GigCapital announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVYA

Avaya

$12.42

-0.1 (-0.80%)

13:36
08/19/19
08/19
13:36
08/19/19
13:36
Hot Stocks
Breaking Hot Stocks news story on Avaya »

Avaya Holdings trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

RRC

Range Resources

$4.47

0.37 (9.02%)

13:35
08/19/19
08/19
13:35
08/19/19
13:35
Upgrade
Range Resources rating change at MKM Partners »

Range Resources rises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVYA

Avaya

$12.39

-0.13 (-1.04%)

13:33
08/19/19
08/19
13:33
08/19/19
13:33
Periodicals
Avaya said to get bid from Mitel, Bloomberg says »

Mitel, which has gone…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

AVYA

Avaya

$12.38

-0.14 (-1.12%)

13:30
08/19/19
08/19
13:30
08/19/19
13:30
Hot Stocks
Breaking Hot Stocks news story on Avaya »

Avaya Holdings trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
08/19/19
08/19
13:17
08/19/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
08/19/19
08/19
13:16
08/19/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$211.42

4.98 (2.41%)

12:51
08/19/19
08/19
12:51
08/19/19
12:51
Periodicals
Apple Arcade to likely be priced at $4.99/month, 9to5Mac reports »

Apple Arcade,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSM

Fortuna Silver Mines

$3.67

-0.01 (-0.27%)

12:48
08/19/19
08/19
12:48
08/19/19
12:48
Hot Stocks
Fortuna Silver reports fatal accident at San Jose mine »

Fortuna Silver Mines said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVRA

Savara

$2.23

0.03 (1.36%)

12:40
08/19/19
08/19
12:40
08/19/19
12:40
Conference/Events
Savara management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

G

Genpact

$41.30

0.51 (1.25%)

, FB

Facebook

$186.67

3.25 (1.77%)

12:40
08/19/19
08/19
12:40
08/19/19
12:40
Periodicals
Facebook contractor raises wages for Indian content reviewers, Reuters reports »

Genpact (G), a Facebook…

G

Genpact

$41.30

0.51 (1.25%)

FB

Facebook

$186.67

3.25 (1.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 24

    Sep

  • 27

    Oct

KAR

KAR Auction

$25.67

0.18 (0.71%)

12:39
08/19/19
08/19
12:39
08/19/19
12:39
Conference/Events
KAR Auction management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 11

    Sep

  • 23

    Sep

  • 13

    Nov

ZS

Zscaler

$74.34

-6.5 (-8.04%)

12:37
08/19/19
08/19
12:37
08/19/19
12:37
Recommendations
Zscaler analyst commentary at OTR Global »

Zscaler slides after OTR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 10

    Oct

  • 15

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.